INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹256 Cr | ₹205 Cr | ₹194 Cr | ₹88 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹44 Cr |
How is Total Non-Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹256 Cr | 25.03 | |
| Mar2024 | ₹205 Cr | 5.35 | |
| Mar2023 | ₹194 Cr | 120.40 | |
| Mar2022 | ₹88 Cr | 97.99 | |
| Mar2021 | ₹44 Cr | - | |
Compare Total Non-Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,825.5 Cr | -1.5% | -3.6% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.5% |
-3.6% |
-13.7% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses